Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

nts who discontinued study therapy in ETV-027, and subsequently restarted treatment in rollover study ETV-901, with a greater than 60 day gap between end of treatment in study ETV-027 and start of treatment in study ETV-901.

    -- ETV-027 compared 0.5 mg of BARACLUDE vs. 100 mg of lamivudine in
nucleoside-naive chronic HBeAg-negative chronic hepatitis B patients.
-- Rollover study ETV-901 was established as an open-label, follow-up
protocol for patients in phase II and III studies of BARACLUDE.
-- Due to ongoing blinding of study ETV-027, most patients retreated in
ETV-901 initially received a combination of 1 mg of BARACLUDE plus 100
mg of lamivudine, and were subsequently switched to 1 mg of BARACLUDE
monotherapy.

The analysis cohort was defined regardless of treatment response at the end of dosing in study ETV-027, and independent of virologic or ALT measurements at the start of dosing in study ETV-901. During off-treatment follow-up, the majority of patients had recurrent levels of hepatitis B virus in the blood (viremia) and increases in ALT.

    Data Results
At the end of dosing for study ETV-027:
-- 94 percent (n=93/99) of the re-treatment cohort had undetectable viral
load
-- 78 percent (n=77/99) had ALT normalization
At entry into ETV-901:
-- Four percent (n=4/99) of patients had undetectable viral load
-- Eight percent (n=8/97) of patients had ALT normalization
Following re-treatment in study ETV-901:
-- 93 percent (n=82/88) of patients had undetectable viral load (HBV DNA
<300 copies/mL) by week 48 of re-treatment with BARACLUDE
-- 83 percent (n=79/95) of patients had ALT normalization (ALT less than
or equal to 1 times the upper limit of normal) by week 48 of re-
treatment BARACLUDE
Adverse events in study ETV-027/901 re-treatment cohort:
-- 67 percent (n=66/99) of patients experienced an adverse event. The most
common adverse events occurring in greater than ten percent of patients
were abdominal pain, fa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:7/24/2014)... --  Royal Philips (NYSE: PHG ... clearance from the U.S. Food and Drug Administration to ... the U.S. VISIQ is the first Philips ... performance and simplicity into a single miniaturized solution, helping ... OB patients. This breakthrough ultrasound device can ...
(Date:7/24/2014)... 2014  Bruin Biometrics (BBI), a pioneer in ... two weeks of clinical briefings to over 200 ... gained substantial concurrence on both the clinical validity ... of BBI,s SEM Scanner. "From ... respondents drawn from the European Wound Management Association ...
(Date:7/24/2014)... -- As part of its ongoing effort to help women pharmacists ... Ownership Boot Camp on July 26 as part of the ... D.C. The Boot Camp is designed ... own their own pharmacies.  Now in its third year, the ... women pharmacists who dream of owning a pharmacy.   ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 2Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 2'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 3'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership 4
... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI") and Target ... the signing of expanded strategic technology license and ... now has the right to use PBI,s patented ... their planned entry into the clinical diagnostics testing ...
... 2012  Arthrosurface, Inc. ( www.arthrosurface.com ), the developer ... March, it surpassed $100 Million in cumulative net ... achievement for the Company, its management believes that ... patients seeking alternatives to total joint replacement procedures. ...
Cached Medicine Technology:Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 2Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 3Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 4Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 5Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services 6Arthrosurface Hits a $100 Million Milestone 2
(Date:7/24/2014)... Texas Physical Therapy Specialists ’ ... installation of the AlterG Anti-Gravity Treadmill , a ... to continue training stress-free while recovering from injury. , ... July 2014, uses technology created by NASA to enable ... 80% of the weight normally included in these activities. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 ... represents a rapidly expanding sector in the in-vitro ... specimen collection devices, new detection technologies, computers, and ... sensitivity, versatility, and speed. In addition to disease ... its benefits in patient stratification, drug regimen selection, ...
(Date:7/24/2014)... ReNewLifeCleansing.com was inspired by ReNew Life ... While waging her battle with poor health, she discovered ... her recovery. She became an expert on cleansing, detoxification, ... minerals, and other ingredients derived from nature help support ... waste and toxins for better overall health. , “Lately, ...
(Date:7/24/2014)... Skin management experts at FACE Skincare Medical Wellness ... the Geneo™ 3-in-1 Super Facial, specifically designed to increase ... large pores, leaving skin looking radiant. FACE is one ... treatment from Israel, and the first and only ... treatment. , This innovative treatment uses the unique ...
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Helps Patients Recover With AlterG Anti-Gravity Treadmill 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 4Health News:ReNew Life Launches New Educational Cleansing & Detox Website—ReNewLifeCleansing.com 2Health News:FACE Skincare Medical Wellness Debuts Exclusive 3-in-1 Facial Treatment in Michigan 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4
... transplanted almost half of face taken from a brain dead donor ... from the lips, nose and chin was taken and transplanted to ... ,Doctors have clarified that the face the woman ... not resemble the donor’s face. ,If accepted the real ...
... international team of researchers has revealed that the inhalers ... chances of an attack.// Mathematical modeling techniques have been ... an asthma attack is likely to take place. The ... study. ,Silverman, professor of child health in the ...
... to make improvements in the services it provides children. ... ill should not be compelled to visit // hospitals for ... Department of Health which insists that individual needs must be ... at home like nurse led services. , It should ...
... been paying lesser attention to programs with regard to ... social development. The Social Development Research Group of the ... almost 600 students which revealed that tackling anti-social tendencies ... contributes towards better academic performance. ,The progress reported ...
... The application of anti-microbial coating over artificial implants such ... to reduce the infection rates following surgery. // This ... the health care cost and an improvement in the ... surgery, the implantable devices are prone for infection. In ...
... is all praise for the healthcare facilities available in India ... The surgery at the Ramaiah Memorial Hospital has cured her ... as she was unable to get the treatment on the ... her 5,000 pounds. The NHS in the UK has come ...
Cached Medicine News:Health News:Asthma Attacks May Be Triggered By Inhalers 2Health News:Anti-Microbial Coating For Use Over Biomedical Devices Developed 2Health News:Indian Healthcare Facilities Come In For Praise 2
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery....
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Low-profile hand-held instruments....
Medicine Products: